Matthias Mann, director of the Max Planck Institute of Biochemistry, has been awarded the 2012 Louis-Jeantet Prize for Medicine and the 2012 Ernst Schering Prize for his work developing mass spectrometry procedures for protein analysis and methods for large-scale proteomics.
Mann also serves as coordinator for the European Commission's PROSPECTS – Proteomics Specification in Time and Space – program.
Quest Diagnostics has named Stephen Rusckowski as president and CEO, succeeding Surya Mohapatra. He will also become a member of the board of directors.
Rusckowski is currently CEO of Philips Healthcare. Before that he held a variety of management positions in the healthcare division of Hewlett-Packard/Agilent Technologies.
Quest also announced that Daniel Stanzione will become non-executive chairman of the board.
The Critical Path Institute has chosen Steven Broadbent as its new chief operating officer. Broadbent will take over for Rick Myers, who recently stepped down from the post in order to focus on his role as chairman of the Arizona Board of Regents. Myers will remain a member of C-Path's board of directors.
Since early 2009, Broadbent has been the director of consortia operations at the institute. Before joining C-Path, Broadbent was an executive at IBM for nearly 31 years.